SlideShare ist ein Scribd-Unternehmen logo
1 von 20
eHealth Chris L. Waller, Ph.D. 1
The global health and life sciences market is a large, complex and highly fragmented. While “data” is flowing  freely through the system unabated, an “information” gap has formed. Providers Payers Regulators Policy Makers Accreditation Entities Govt. Programs Diagnostic Services/ GCRCs Employers Regulations Applications and Approvals Licenses Licensed Health Prof’nals Consumers/ Patients $ Coverage Health Plans/ Care Premium $ Health Delivery Systems/ Facilities $ $ $ Carve Outs (PBMs,  others) “orders” Products Pharmacies Pharma. (including Biotech)  Medical Products Contract Services Nursing and Home Health Global Insurers Distributors Info Companies Generic Mfgs. Products The Worldwide  Healthcare Ecosystem
What is Happening in HIT: Growing HIT Momentum in the US Selected Critical  Developments Projected Timeline 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 MMA mandates federal eRx standards by 2009 Healthcare Reform Enacted. $35B alloc. to HIT Pressure to Accelerate June 2005 AHIC & RFPs Announced Pressure to Accelerate Mar 2001 Landmark IOM study “Crossing the Quality Chasm” identifies rampant errors and urges HIT Dec 2003 MMA becomes law.  Pfizer leads successful effort to block federal eRx mandate, but timetable is set              to drive eRx standards process Jul 2004ONCHIT releases strategic framework          for NHII ARRA: majority of Americans use EMRs by  2015 Kerry Pledge: 100% EHR use by 2008 Pressure to Accelerate June 2004 RAND study estimates that Americans receive only 55% of recommended care and proposes HIT- based solutions Apr 2004 Presidential Executive Order sets EHR adoption goal, and appoints Dr. David Brailer to lead the Office of the National HIT Coordinator (ONCHIT) Note:	ONCHIT = Office of the National Health Information Technology 	Coordinator NHII = National Health Information Infrastructure MMA = Medicare Modernization Act
HITECH The Health Information Technology for Economic and Clinical Health (HITECH) Act, enacted as part of the American Recovery and Reinvestment Act of 2009, was signed into law on February 17, 2009, to promote the adoption and meaningful use of health information technology.   DIVISION A: TITLE XIII—HEALTH INFORMATION TECHNOLOGY Subtitle A—Promotion of Health Information Technology PART 1—IMPROVING HEALTH CARE QUALITY, SAFETY, AND EFFICIENCY PART 2—Application and use of adopted health information technology standards; Reports Subtitle B—Testing of Health Information Technology Subtitle C—Grants and Loans Funding Subtitle D—Privacy PART 1—IMPROVED PRIVACY PROVISIONS AND SECURITY PROVISIONS PART 2—RELATIONSHIP TO OTHER LAWS; REGULATORY REFERENCES; EFFECTIVE DATE; REPORTS DIVISION B: TITLE IV—MEDICARE AND MEDICAID HEALTH INFORMATION TECHNOLOGY; MISCELLANEOUS MEDICARE PROVISIONS Subtitle A—Medicare Incentives Subtitle B—Medicaid Incentives Subtitle C—Miscellaneous Medicare Provisions
eHealth at Pfizer (2010) We developed a capability called eHealth, which is a group that focuses on thinking about the convergence of healthcare and information technology.  Over the last nine months, we’ve made three investments in companies that are in the e-Health space: Private Access, Keas, and Acacia Living. All three are focused on driving consumer outcomes-based healthcare. They’re in the vein of personalizing medical treatment, health and wellness; and they’re in the vein of decentralizing health and wellness so that consumers are more responsible and more engaged, as well as their communities and caregivers. Another capability is looking at complex partnerships between large players effecting healthcare to solve very complex problems requiring multi-player solutions. So, we’ve been building the capability to think about multiple-player collaboration and business models. One of the investments that we made in the last nine months is Private Access. It is enabling a collaborative model, which addresses clinical trial improvement through building an eco-system across the industry, bringing multiple stakeholders, government, private sector, and society together in a coherent and consolidated way. From an interview with Usama Malik. http://www.innovate1st.com/newsletter/october%202010/TheInnovators.html
eHealth Steering Committee WWS&I WWBD WW BT WW Policy Technology Strategy Strategy Setting Search & Evaluation US Policy Strategy Technology Standards Program Management Due Diligence US Advocacy Technology Evaluation Business Architecture Deal Negotiation Intl. Policy Strategy Technology Architecture Alliance Management Investment Management Intl. Advocacy Technology Delivery
eHealth: Convergence of Healthcare and Technology Patient-centric Provider-centric Care provision augmentation Health & Wellness Consumer Electronics  Business Diversification beyond Pharma New Product and Services Health & Wellness Self-Management Services Clinical Decision Support Aids Uses of Clinical Data for R&D Adverse Event Reporting Utility Health Economics Analytics Business Innovation within Pharma Clinical Data Flow and Uses 7
Data Analysis Medical History External Data (Labs, Other providers) Presenting problem Clinical & Claims  Data ,[object Object]
Cost effective
Drug safety
Epidemiology
Bio surveillancePatient Physician Pay forPerformance Formulary/Individual Benefit ConsumerScorecard Robust Decision Support PHRs Protocol Modeling & Assessment, Site Selection, Patient Recruitment RetrospectiveEvidence PhysicianMetrics PACeR and the HIT Pipeline for Research Consumers, healthcare providers, policy makers and payers are leveraging HIT, particularly Electronic Health Records (eHRs), to analyze health data, contain healthcare costs, and improve quality of clinical care The PACeR Collaborative was established to leverage the HIT Pipeline for Research The Partnership to Advance Clinical electronic Research (PACeR) is a collaboration between Pfizer and other leading pharmaceutical companies, health technology vendors, New York-based academic medical centers, standards organizations, and regulators to build an advanced clinical research capability enabled by the re-purposing of electronic clinical care data. PACeR’s Primary Goals are: ,[object Object]
Establish a sustainable business framework and exchange where are all stakeholders realize economic benefit
Identify regulatory and legal issues, implications for business models, and data and systems necessary for success
Develop a practical, implementable, roadmap, addressing the requirements of all stakeholders,[object Object]
Keas Mission:consumersto take charge of their www.keas.com Keas: Empower Consumers
Core solution WellnessProgram B.  Wellness “engine” Complete health & wellness assessment under consent 1 2 Suggest interventions based on results SMS Track selected data (activity, weight, diet, stress, sleep time, work time, ... ) on defined intervals 3 Provide instant feedback, encouragement and guidance based on data 4 ,[object Object]
Track own progress compared to others,
Challenge others
Participate in company wellness initatives5 A.  Employee with wellness application C.  “Wellness program site” Activate coach service based selected criteria ,[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiTTC, llc
 
Integrate RWE into clinical development
Integrate RWE into clinical developmentIntegrate RWE into clinical development
Integrate RWE into clinical developmentIMSHealthRWES
 
J & J Solutions Executive Summary 1 Page
J & J Solutions Executive Summary 1 PageJ & J Solutions Executive Summary 1 Page
J & J Solutions Executive Summary 1 Pageinnovate_with_us
 
Disruptive Strategies for Removing Drug Discovery Bottlenecks
Disruptive Strategies for Removing Drug Discovery Bottlenecks Disruptive Strategies for Removing Drug Discovery Bottlenecks
Disruptive Strategies for Removing Drug Discovery Bottlenecks Sean Ekins
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
 
Fulgent Genetics - Biotech - Total return >200%
Fulgent Genetics - Biotech - Total return >200%Fulgent Genetics - Biotech - Total return >200%
Fulgent Genetics - Biotech - Total return >200%Rogelio Rea
 
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014Will Zasadny
 
Cros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trends
Cros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trendsCros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trends
Cros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trendsAllu Sridhar Venkat
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The MarkeTech Group
 
Oracle Health Science
Oracle Health ScienceOracle Health Science
Oracle Health ScienceCallum Bir
 
Oncology Intelligence Report 2014 Broucher
Oncology Intelligence Report 2014 BroucherOncology Intelligence Report 2014 Broucher
Oncology Intelligence Report 2014 BroucherOmicsX
 
Future of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationFuture of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationSaama
 

Was ist angesagt? (20)

Two Heads
Two HeadsTwo Heads
Two Heads
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
 
E Pluribus Unum: Out of Many, One
E Pluribus Unum: Out of Many, OneE Pluribus Unum: Out of Many, One
E Pluribus Unum: Out of Many, One
 
Integrate RWE into clinical development
Integrate RWE into clinical developmentIntegrate RWE into clinical development
Integrate RWE into clinical development
 
Strand genomics features in CIO review
Strand genomics features in CIO reviewStrand genomics features in CIO review
Strand genomics features in CIO review
 
J & J Solutions Executive Summary 1 Page
J & J Solutions Executive Summary 1 PageJ & J Solutions Executive Summary 1 Page
J & J Solutions Executive Summary 1 Page
 
Life Sciences Trends 2014
Life Sciences Trends 2014Life Sciences Trends 2014
Life Sciences Trends 2014
 
Disruptive Strategies for Removing Drug Discovery Bottlenecks
Disruptive Strategies for Removing Drug Discovery BottlenecksDisruptive Strategies for Removing Drug Discovery Bottlenecks
Disruptive Strategies for Removing Drug Discovery Bottlenecks
 
Disruptive Strategies for Removing Drug Discovery Bottlenecks
Disruptive Strategies for Removing Drug Discovery Bottlenecks Disruptive Strategies for Removing Drug Discovery Bottlenecks
Disruptive Strategies for Removing Drug Discovery Bottlenecks
 
Data Driven Health Care Enterprise
Data Driven Health Care EnterpriseData Driven Health Care Enterprise
Data Driven Health Care Enterprise
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
Fulgent Genetics - Biotech - Total return >200%
Fulgent Genetics - Biotech - Total return >200%Fulgent Genetics - Biotech - Total return >200%
Fulgent Genetics - Biotech - Total return >200%
 
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
CHI-Report-Taking-the-Pulse-of-Medical-Device-Regulation-Innovation_Oct-2014
 
Cros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trends
Cros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trendsCros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trends
Cros and other_outsourced_pharmaceutical_support_services_m_a_drivers_and_trends
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011
 
Oracle Health Science
Oracle Health ScienceOracle Health Science
Oracle Health Science
 
12JA-ISPE
12JA-ISPE12JA-ISPE
12JA-ISPE
 
Four Disruptive Strategies for Removing Drug Discovery Bottlenecks
Four Disruptive Strategies for Removing Drug Discovery BottlenecksFour Disruptive Strategies for Removing Drug Discovery Bottlenecks
Four Disruptive Strategies for Removing Drug Discovery Bottlenecks
 
Oncology Intelligence Report 2014 Broucher
Oncology Intelligence Report 2014 BroucherOncology Intelligence Report 2014 Broucher
Oncology Intelligence Report 2014 Broucher
 
Future of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationFuture of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentation
 

Ähnlich wie BioIT World 2011 eHealth

21st Century Act and its Impact on Healthcare IT
21st Century Act and its Impact on Healthcare IT21st Century Act and its Impact on Healthcare IT
21st Century Act and its Impact on Healthcare ITCitiusTech
 
Cherian&Associates 10 Health Innovations
Cherian&Associates 10 Health InnovationsCherian&Associates 10 Health Innovations
Cherian&Associates 10 Health Innovationsmzeta
 
Fda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivFda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivNathan White, CPC
 
Health Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptxHealth Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptxArti Parab Academics
 
Cortese/Korsmo Presentation
Cortese/Korsmo PresentationCortese/Korsmo Presentation
Cortese/Korsmo PresentationLee Aase
 
Data-driven Healthcare for Providers
Data-driven Healthcare for ProvidersData-driven Healthcare for Providers
Data-driven Healthcare for ProvidersLindaWatson19
 
Data driven Healthcare for Providers
Data driven Healthcare for ProvidersData driven Healthcare for Providers
Data driven Healthcare for ProvidersAmit Mishra
 
Emerose galvez
Emerose galvezEmerose galvez
Emerose galvezemerosegal
 
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015Arda Ural, MSc, MBA, PhD
 
Data-driven Healthcare for Payers
Data-driven Healthcare for PayersData-driven Healthcare for Payers
Data-driven Healthcare for PayersLindaWatson19
 
MakeHx At a Glance - August 2014
MakeHx At a Glance - August 2014MakeHx At a Glance - August 2014
MakeHx At a Glance - August 2014makehx
 
Electronic Health Records - Market Landscape
Electronic Health Records - Market LandscapeElectronic Health Records - Market Landscape
Electronic Health Records - Market LandscapeHarrison Hayes, LLC
 
Issues in informatics
Issues in informaticsIssues in informatics
Issues in informaticsloveobi25
 
Analytics_Wealth of Infomation
Analytics_Wealth of InfomationAnalytics_Wealth of Infomation
Analytics_Wealth of InfomationHeather Fraser
 
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docxAssignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docxbraycarissa250
 

Ähnlich wie BioIT World 2011 eHealth (20)

21st Century Act and its Impact on Healthcare IT
21st Century Act and its Impact on Healthcare IT21st Century Act and its Impact on Healthcare IT
21st Century Act and its Impact on Healthcare IT
 
Cherian&Associates 10 Health Innovations
Cherian&Associates 10 Health InnovationsCherian&Associates 10 Health Innovations
Cherian&Associates 10 Health Innovations
 
Fda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivFda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In Ventiv
 
Health Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptxHealth Informatics- Module 4-Chapter 2.pptx
Health Informatics- Module 4-Chapter 2.pptx
 
Cortese/Korsmo Presentation
Cortese/Korsmo PresentationCortese/Korsmo Presentation
Cortese/Korsmo Presentation
 
Data-driven Healthcare for Providers
Data-driven Healthcare for ProvidersData-driven Healthcare for Providers
Data-driven Healthcare for Providers
 
Data driven Healthcare for Providers
Data driven Healthcare for ProvidersData driven Healthcare for Providers
Data driven Healthcare for Providers
 
Emerose galvez
Emerose galvezEmerose galvez
Emerose galvez
 
Mikhaela ripa
Mikhaela ripaMikhaela ripa
Mikhaela ripa
 
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
Accenture Transformative Power of Healthcare Technology M&A in Life Science 2015
 
Washington State BioMed Summit - Steve Halasey InHealth Presentation
Washington State BioMed Summit - Steve Halasey InHealth PresentationWashington State BioMed Summit - Steve Halasey InHealth Presentation
Washington State BioMed Summit - Steve Halasey InHealth Presentation
 
SupplyChain-ISSUU
SupplyChain-ISSUUSupplyChain-ISSUU
SupplyChain-ISSUU
 
Data-driven Healthcare for Payers
Data-driven Healthcare for PayersData-driven Healthcare for Payers
Data-driven Healthcare for Payers
 
MakeHx At a Glance - August 2014
MakeHx At a Glance - August 2014MakeHx At a Glance - August 2014
MakeHx At a Glance - August 2014
 
Summary of Top Ten Health Industry Issues
Summary of Top Ten Health Industry IssuesSummary of Top Ten Health Industry Issues
Summary of Top Ten Health Industry Issues
 
Electronic Health Records - Market Landscape
Electronic Health Records - Market LandscapeElectronic Health Records - Market Landscape
Electronic Health Records - Market Landscape
 
Issues in informatics
Issues in informaticsIssues in informatics
Issues in informatics
 
Analytics_Wealth of Infomation
Analytics_Wealth of InfomationAnalytics_Wealth of Infomation
Analytics_Wealth of Infomation
 
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docxAssignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
Assignment 1 Legal Aspects of U.S. Health Care System Administrat.docx
 
Nicolas Terry, "Big Data, Regulatory Disruption, and Arbitrage in Health Care"
Nicolas Terry, "Big Data, Regulatory Disruption, and Arbitrage in Health Care"Nicolas Terry, "Big Data, Regulatory Disruption, and Arbitrage in Health Care"
Nicolas Terry, "Big Data, Regulatory Disruption, and Arbitrage in Health Care"
 

BioIT World 2011 eHealth

  • 1. eHealth Chris L. Waller, Ph.D. 1
  • 2. The global health and life sciences market is a large, complex and highly fragmented. While “data” is flowing freely through the system unabated, an “information” gap has formed. Providers Payers Regulators Policy Makers Accreditation Entities Govt. Programs Diagnostic Services/ GCRCs Employers Regulations Applications and Approvals Licenses Licensed Health Prof’nals Consumers/ Patients $ Coverage Health Plans/ Care Premium $ Health Delivery Systems/ Facilities $ $ $ Carve Outs (PBMs, others) “orders” Products Pharmacies Pharma. (including Biotech) Medical Products Contract Services Nursing and Home Health Global Insurers Distributors Info Companies Generic Mfgs. Products The Worldwide Healthcare Ecosystem
  • 3. What is Happening in HIT: Growing HIT Momentum in the US Selected Critical Developments Projected Timeline 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 MMA mandates federal eRx standards by 2009 Healthcare Reform Enacted. $35B alloc. to HIT Pressure to Accelerate June 2005 AHIC & RFPs Announced Pressure to Accelerate Mar 2001 Landmark IOM study “Crossing the Quality Chasm” identifies rampant errors and urges HIT Dec 2003 MMA becomes law. Pfizer leads successful effort to block federal eRx mandate, but timetable is set to drive eRx standards process Jul 2004ONCHIT releases strategic framework for NHII ARRA: majority of Americans use EMRs by 2015 Kerry Pledge: 100% EHR use by 2008 Pressure to Accelerate June 2004 RAND study estimates that Americans receive only 55% of recommended care and proposes HIT- based solutions Apr 2004 Presidential Executive Order sets EHR adoption goal, and appoints Dr. David Brailer to lead the Office of the National HIT Coordinator (ONCHIT) Note: ONCHIT = Office of the National Health Information Technology Coordinator NHII = National Health Information Infrastructure MMA = Medicare Modernization Act
  • 4. HITECH The Health Information Technology for Economic and Clinical Health (HITECH) Act, enacted as part of the American Recovery and Reinvestment Act of 2009, was signed into law on February 17, 2009, to promote the adoption and meaningful use of health information technology.  DIVISION A: TITLE XIII—HEALTH INFORMATION TECHNOLOGY Subtitle A—Promotion of Health Information Technology PART 1—IMPROVING HEALTH CARE QUALITY, SAFETY, AND EFFICIENCY PART 2—Application and use of adopted health information technology standards; Reports Subtitle B—Testing of Health Information Technology Subtitle C—Grants and Loans Funding Subtitle D—Privacy PART 1—IMPROVED PRIVACY PROVISIONS AND SECURITY PROVISIONS PART 2—RELATIONSHIP TO OTHER LAWS; REGULATORY REFERENCES; EFFECTIVE DATE; REPORTS DIVISION B: TITLE IV—MEDICARE AND MEDICAID HEALTH INFORMATION TECHNOLOGY; MISCELLANEOUS MEDICARE PROVISIONS Subtitle A—Medicare Incentives Subtitle B—Medicaid Incentives Subtitle C—Miscellaneous Medicare Provisions
  • 5. eHealth at Pfizer (2010) We developed a capability called eHealth, which is a group that focuses on thinking about the convergence of healthcare and information technology. Over the last nine months, we’ve made three investments in companies that are in the e-Health space: Private Access, Keas, and Acacia Living. All three are focused on driving consumer outcomes-based healthcare. They’re in the vein of personalizing medical treatment, health and wellness; and they’re in the vein of decentralizing health and wellness so that consumers are more responsible and more engaged, as well as their communities and caregivers. Another capability is looking at complex partnerships between large players effecting healthcare to solve very complex problems requiring multi-player solutions. So, we’ve been building the capability to think about multiple-player collaboration and business models. One of the investments that we made in the last nine months is Private Access. It is enabling a collaborative model, which addresses clinical trial improvement through building an eco-system across the industry, bringing multiple stakeholders, government, private sector, and society together in a coherent and consolidated way. From an interview with Usama Malik. http://www.innovate1st.com/newsletter/october%202010/TheInnovators.html
  • 6. eHealth Steering Committee WWS&I WWBD WW BT WW Policy Technology Strategy Strategy Setting Search & Evaluation US Policy Strategy Technology Standards Program Management Due Diligence US Advocacy Technology Evaluation Business Architecture Deal Negotiation Intl. Policy Strategy Technology Architecture Alliance Management Investment Management Intl. Advocacy Technology Delivery
  • 7. eHealth: Convergence of Healthcare and Technology Patient-centric Provider-centric Care provision augmentation Health & Wellness Consumer Electronics Business Diversification beyond Pharma New Product and Services Health & Wellness Self-Management Services Clinical Decision Support Aids Uses of Clinical Data for R&D Adverse Event Reporting Utility Health Economics Analytics Business Innovation within Pharma Clinical Data Flow and Uses 7
  • 8.
  • 12.
  • 13. Establish a sustainable business framework and exchange where are all stakeholders realize economic benefit
  • 14. Identify regulatory and legal issues, implications for business models, and data and systems necessary for success
  • 15.
  • 16. Keas Mission:consumersto take charge of their www.keas.com Keas: Empower Consumers
  • 17.
  • 18. Track own progress compared to others,
  • 20.
  • 21. Contact coach proactively to get persolized support7 6 D. Wellness coach
  • 22.
  • 27. Financial and health incentive trackers
  • 29. Select employer partner to participate in the experiment
  • 30. Demonstrate value of program to other employers to support reimbursementiPhone Our Goal: - Demonstrate Behavior Modification - Improved Medication Adherence, Persistence, and Quit Rates
  • 33. Summary of Pfizer’s HIT Efforts Support and Transform Medical Practice Adverse Drug Event Spontaneous Electronic Reporting (ASTER) 217 reports in 5 mons. vs. 0 (25% “serious”) 7x as much (structured) data as normal report Support Patient-Centric Healthcare Keas Text4Baby Nutrition, flu prevention, immunization, etc. Free, 100,000 subscribers G.C. Simon, AJMC-2010-08-0217
  • 34. Summary of Pfizer’s HIT Efforts Improve Clinical Trials Private Access PACeR Clinical Trial Atlas Partnership with National Minority Quality Forum to collect and map trial data to demographics Expedite Research Connecting for Drug Safety Collaboration of the eHealthInitative Safety Surveillance in electronic healthcare data Observational Medical Outcomes Partnership (OMOP) 2 year pilot to develop methods to query databases to assess safety of drugs on market G.C. Simon, AJMC-2010-08-0217
  • 35. Recommendations Embrace and Fully Fund Public-Private Partnerships Development of a National Clinical Trials Infrastructure Development of Systems that Provide Selective Sharing of Electronic Health Data Development of HIT Platforms that Allow Physicians Access to All Approved Options to Inform Decisions for Patients’ Health Implement an Incentive Model that Encourages Sustained Investment in HIT G.C. Simon, AJMC-2010-08-0217
  • 36. eHealth at Pfizer (2011) Connected Health Contact Usama Malik for more information
  • 37. Acknowledgements David Leventhal Chris Waller Shaf Madina Ben Bandaru Mark Brincat

Hinweis der Redaktion

  1. http://healthsystemcio.com/2010/08/11/collaborative-care-the-thing-after-hie%E2%80%99s/http://ehr.healthcareitnews.com/blog/ehrs-are-just-stepping-stone